Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy
The DOI matches its Crossref record.
Abstract
Using a placebo-controlled, double-blind cross-over study the potential therapeutic effect of ubiquinone (coenzyme Q10) was investigated in 25 patients suffering from idiopathic dilated cardiomyopathy (New York Heart Association functional classification I, II and III). Over an initial period of 4 months, 15 patients were administered verum (3 x 33.3 mg coenzyme Q10 x day-1 p.o.) and subsequently given a placebo during the ensuing 4 months (V/P). The sequence of treatment was reversed within the remaining 10 patients (P/V). Therapeutic efficacy was assessed by means of echocardiogram, chest X-ray, radionuclide ventriculography in combination with exercise test and impedance cardiography. Control values for left ventricular function parameters were similar in both groups; left ventricular ejection fraction: 39.5 +/- 11.5% (P/V), 37.6 +/- 17.0% (V/P); left ventricular end-diastolic diameter: 65 +/- 9 mm (P/V), 67 +/- 8 mm (P/V); and cardiac output: 5.1 +/- 1.41 x min-1 (P/V), 5.1 +/- 1.11 x min-1 (V/P). Chronic treatment with ubiquinone had no influence on haemodynamic parameters, electrocardiogram, incidence of ventricular arrhythmias or on exercise tolerance. It was therefore impossible to demonstrate any therapeutic effect of ubiquinone in patients suffering from idiopathic dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations
Bhagavan, H. N., & Chopra, R. K. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.003 · Cited by 243
“In this context, it may be noted that there are a few studies often cited in the literature where the beneficial effects of CoQ10 supplementation in heart disease could not be demonstrated (Watson et al., 1999; Khatta et al., 2000; Permanetter et al., 1992).”
BackgroundEffect of coenzyme Q10 supplementation on heart failure: a meta-analysis
Fotino, A. D., Thompson-Paul, A. M., & Bazzano, L. A. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.040741 · Cited by 185
“Finally, the change in EF was estimated from figures for one study (16).”
BackgroundMethodRisk assessment for coenzyme Q10 (Ubiquinone)
Hathcock, J. N., & Shao, A. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.05.006 · Cited by 114
Coenzyme Q10 for heart failure
Madmani, M. E., Yusuf Solaiman, A., Tamr Agha, K., Madmani, Y., Shahrour, Y., Essali, A., & Kadro, W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008684.pub2 · Cited by 94
Yang, Y.-K., Wang, L.-P., Chen, L., Yao, X.-P., Yang, K.-Q., Gao, L.-G., & Zhou, X.-L. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.08.002 · Cited by 78
Metadata
- Authors
- PERMANETTER, B., RÖSSY, W., KLEIN, G., WEINGARTNER, F., SEIDL, K. F., & BLOMER, H.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-11
- Volume
- 13
- Issue
- 11
- Pages
- 1528-1533
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W1930777280
- Cited by
- 85
- References
- 0
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. https://app.cochat.ai/papers/10.1093/oxfordjournals.eurheartj.a060096
- The paper
- PERMANETTER, B., RÖSSY, W., KLEIN, G., WEINGARTNER, F., SEIDL, K. F., & BLOMER, H. (1992). Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. European Heart Journal. https://doi.org/10.1093/oxfordjournals.eurheartj.a060096
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.